These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 3546779)

  • 1. Comparable effects of oral diltiazem and verapamil in the treatment of hypertrophic cardiomyopathy. Double-blind crossover study.
    Toshima H; Koga Y; Nagata H; Toyomasu K; Itaya K; Matoba T
    Jpn Heart J; 1986 Sep; 27(5):701-15. PubMed ID: 3546779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of equal-weight oral dosages of verapamil hydrochloride and diltiazem hydrochloride in patients with mild to moderate hypertension.
    Hollifield JW; Heusner JJ; DesChamps M; Gray J; Spyker DA; Peace KE; Dickson B
    Clin Pharm; 1988 Feb; 7(2):129-34. PubMed ID: 3280220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adverse effects of atrial fibrillation and syncope induced by calcium-channel blockers in hypertrophic cardiomyopathy.
    Doiuchi J; Hamada M; Ochi T; Ito T; Kokubu T
    Clin Cardiol; 1985 Mar; 8(3):176-9. PubMed ID: 4038927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A double-blind, placebo-controlled crossover trial of nadolol and verapamil in mild and moderately symptomatic hypertrophic cardiomyopathy.
    Gilligan DM; Chan WL; Joshi J; Clarke P; Fletcher A; Krikler S; Oakley CM
    J Am Coll Cardiol; 1993 Jun; 21(7):1672-9. PubMed ID: 8496536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparison of the efficacy of verapamil and diltiazem in stable exercise angina. A double-blind and crossover study].
    Belin A; Grieu P; Mabire JP; Kleszcz A; Sesboué B; Breut C; Scanu P; Albessard F; Grollier G; Potier JC
    Arch Mal Coeur Vaiss; 1990 Mar; 83(3):393-8. PubMed ID: 2108634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the calcium channel-blocking agents diltiazem and verapamil for treatment of feline hypertrophic cardiomyopathy.
    Bright JM; Golden AL; Gompf RE; Walker MA; Toal RL
    J Vet Intern Med; 1991; 5(5):272-82. PubMed ID: 1836234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of intravenous diltiazem and verapamil for the acute treatment of atrial fibrillation and atrial flutter.
    Phillips BG; Gandhi AJ; Sanoski CA; Just VL; Bauman JL
    Pharmacotherapy; 1997; 17(6):1238-45. PubMed ID: 9399606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A double-blind, randomized, crossover comparison of equivalent (by weight) oral doses of verapamil and diltiazem in patients with mild to moderate hypertension.
    Hollifield JW; Heusner JJ; DesChamps MK; Gray J
    J Cardiovasc Pharmacol; 1989; 13 Suppl 4():S68-70. PubMed ID: 2475693
    [No Abstract]   [Full Text] [Related]  

  • 9. Antianginal efficacy over 24 hours and exercise hemodynamic effects of once daily sustained-release 300 mg diltiazem and 240 mg verapamil in stable angina pectoris.
    De Rosa ML; Giordano A; Melfi M; Della Guardia D; Ciaburri F; Rengo F
    Int J Cardiol; 1998 Jan; 63(1):27-35. PubMed ID: 9482142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improvement in left ventricular diastolic function during intravenous and oral diltiazem therapy in patients with hypertrophic cardiomyopathy: an echocardiographic study.
    Suwa M; Hirota Y; Kawamura K
    Am J Cardiol; 1984 Nov; 54(8):1047-53. PubMed ID: 6541866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral verapamil effects on global and regional left ventricular diastolic filling in hypertrophic cardiomyopathy.
    Yamagishi T; Ozaki M; Kusukawa R
    Jpn Circ J; 1990 Nov; 54(11):1365-73. PubMed ID: 2287041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of diltiazem on left ventricular diastolic behavior in patients with hypertrophic cardiomyopathy: evaluation with exercise pulsed Doppler echocardiography.
    Iwase M; Sotobata I; Takagi S; Miyaguchi K; Jing HX; Yokota M
    J Am Coll Cardiol; 1987 May; 9(5):1099-105. PubMed ID: 3571749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The efficacy and safety of high-dose verapamil and diltiazem in the long-term treatment of stable exertional angina.
    Weiner DA; McCabe CH; Cutler SS; Ryan TJ; Klein MD
    Clin Cardiol; 1984 Dec; 7(12):648-53. PubMed ID: 6391771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of calcium-channel blocking drugs in hypertrophic cardiomyopathy.
    Rosing DR; Idänpään-Heikkilä U; Maron BJ; Bonow RO; Epstein SE
    Am J Cardiol; 1985 Jan; 55(3):185B-195B. PubMed ID: 3881913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of diltiazem on left ventricular systolic and diastolic function in hypertrophic cardiomyopathy.
    Betocchi S; Piscione F; Losi M A; Pace L; Boccalatte M; Perrone-Filardi P; Cappelli-Bigazzi ; Briguori C; Manganelli F; Ciampi Q; Salvatore M; Chiariello M
    Am J Cardiol; 1996 Aug; 78(4):451-7. PubMed ID: 8752192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ventricular rate control and exercise performance in chronic atrial fibrillation: effects of diltiazem and verapamil.
    Lundström T; Rydén L
    J Am Coll Cardiol; 1990 Jul; 16(1):86-90. PubMed ID: 2358610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diltiazem, nifedipine, and their combination in patients with stable angina pectoris: effects on angina, exercise tolerance, and the ambulatory electrocardiographic ST segment.
    Frishman W; Charlap S; Kimmel B; Teicher M; Cinnamon J; Allen L; Strom J
    Circulation; 1988 Apr; 77(4):774-86. PubMed ID: 3280158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparative evaluation using an ergometric test of the efficacy of the 3 major calcium antagonists on exertion stable angina].
    Papa M; Acanfora D; Artiaco D; Santangelo L; Covelluzzi F; De Rosa ML; Cicatiello M; De Caprio L; Rengo F
    G Ital Cardiol; 1987 Apr; 17(4):344-50. PubMed ID: 3653591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparative study of the effects of verapamil and propranolol therapy in 16 cases of obstructive hypertrophic myocardiopathy].
    Cosnay P; Fauchier JP; Lang M; Casset D; Raynaud P; Lavigne G; Itti R
    Arch Mal Coeur Vaiss; 1987 Mar; 80(3):346-55. PubMed ID: 3113357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of verapamil on response of coronary vasomotion to handgrip exercise in symptomatic patients with hypertrophic cardiomyopathy.
    Dimitrow PP; Krzanowski M; Nitankowski R; Szczeklik A; Dubiel JS
    Cardiovasc Drugs Ther; 2001 Jul; 15(4):331-7. PubMed ID: 11800417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.